RecallDepth
Class II Terminated

Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India, NDC 68180-723-20

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
July 2, 2020
Posted
July 29, 2020
Recall Number
D-1406-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
35,928 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.

Distribution

U.S.A. Nationwide

Lot / Code Info

Lot # F802189, Exp 10/2020, F900240, Exp 1/2021

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls